Affinity Asset Advisors’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-109,900
Closed -$2.54M 89
2023
Q4
$2.54M Buy
+109,900
New +$2.54M 0.46% 45
2023
Q3
Hold
0
76